These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 23003335)
1. p16(INK4a) /Ki-67 dual labelling as a marker for the presence of high-grade cancer cells or disease progression in urinary cytopathology. Piaton E; Advenier AS; Carré C; Decaussin-Petrucci M; Mege-Lechevallier F; Ruffion A Cytopathology; 2013 Oct; 24(5):327-34. PubMed ID: 23003335 [TBL] [Abstract][Full Text] [Related]
2. p16 INK4a overexpression and p16/Ki-67 dual labeling versus conventional urinary cytology in the evaluation of urothelial carcinoma. Piaton E; Carré C; Advenier AS; Decaussin-Petrucci M; Mège-Lechevallier F; Lantier P; Granier G; Ruffion A Cancer Cytopathol; 2014 Mar; 122(3):211-20. PubMed ID: 24302621 [TBL] [Abstract][Full Text] [Related]
3. p16/Ki-67 dual labeling and urinary cytology results according to the New Paris System for Reporting Urinary Cytology: Impact of extended follow-up. Piaton E; Advenier AS; Carré C; Decaussin-Petrucci M; Mège-Lechevallier F; Hutin K; Nennig C; Colombel M; Ruffion A Cancer Cytopathol; 2017 Jul; 125(7):552-562. PubMed ID: 28371465 [TBL] [Abstract][Full Text] [Related]
4. Value of p16(INK4a) in the diagnosis of low-grade urothelial carcinoma of the urinary bladder in urinary cytology. Alameda F; Juanpere N; Pijuan L; Lloveras B; Gimeno J; Baró T; Salido M; Serrano S; Lloreta J Cancer Cytopathol; 2012 Aug; 120(4):276-82. PubMed ID: 22419364 [TBL] [Abstract][Full Text] [Related]
5. p16(INK4a) overexpression is not linked to oncogenic human papillomaviruses in patients with high-grade urothelial cancer cells. Piaton E; Casalegno JS; Advenier AS; Decaussin-Petrucci M; Mege-Lechevallier F; Ruffion A; Mekki Y Cancer Cytopathol; 2014 Oct; 122(10):760-9. PubMed ID: 25069600 [TBL] [Abstract][Full Text] [Related]
6. Genotyping of high-risk human papillomaviruses in p16/Ki-67-positive urothelial carcinoma cells: even a worm will turn. Advenier AS; Casalegno JS; Mekki Y; Decaussin-Petrucci M; Mège-Lechevallier F; Ruffion A; Piaton E Cytopathology; 2015 Apr; 26(2):106-13. PubMed ID: 24785530 [TBL] [Abstract][Full Text] [Related]
7. HPV16 genotype, p16/Ki-67 dual staining and koilocytic morphology as potential predictors of the clinical outcome for cervical low-grade squamous intraepithelial lesions. Vrdoljak-Mozetič D; Krašević M; Verša Ostojić D; Štemberger-Papić S; Rubeša-Mihaljević R; Bubonja-Šonje M Cytopathology; 2015 Feb; 26(1):10-8. PubMed ID: 24261348 [TBL] [Abstract][Full Text] [Related]
8. p16ink4 immunoreactivity is a reliable marker for urothelial carcinoma in situ. Yin M; Bastacky S; Parwani AV; McHale T; Dhir R Hum Pathol; 2008 Apr; 39(4):527-35. PubMed ID: 18234280 [TBL] [Abstract][Full Text] [Related]
9. p16(INK4a) expression analysis as an ancillary tool for cytologic diagnosis of urothelial carcinoma. Nakazawa K; Murata S; Yuminamochi T; Ishii Y; Ohno S; Nakazawa T; Kondo T; Katoh R Am J Clin Pathol; 2009 Nov; 132(5):776-84. PubMed ID: 19846821 [TBL] [Abstract][Full Text] [Related]
10. Immunocytochemical staining for p53 and Ki-67 helps to characterise urothelial cells in urine cytology. Courtade-Saïdi M; Aziza J; d'Aure D; Bérard E; Evrard S; Basset C; Lacoste-Collin L Cytopathology; 2016 Dec; 27(6):456-464. PubMed ID: 27873391 [TBL] [Abstract][Full Text] [Related]
11. Usefulness of NMP22 as an adjunct to a typical urine cytology and low-grade urothelial carcinoma. Arora VK; Sarungbam J; Bhatia A; Singh N; Agrawal V; Aggarwal S Diagn Cytopathol; 2010 Nov; 38(11):788-90. PubMed ID: 20014314 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of p16INK4A in liquid-based specimens (SurePath) as marker of cervical dysplasia and neoplasia. Saqi A; Pasha TL; McGrath CM; Yu GH; Zhang P; Gupta P Diagn Cytopathol; 2002 Dec; 27(6):365-70. PubMed ID: 12451568 [TBL] [Abstract][Full Text] [Related]
13. Aberrant expression of p53, p16INK4a and Ki-67 as basic biomarker for malignant progression of oral leukoplakias. Nasser W; Flechtenmacher C; Holzinger D; Hofele C; Bosch FX J Oral Pathol Med; 2011 Sep; 40(8):629-35. PubMed ID: 21435003 [TBL] [Abstract][Full Text] [Related]
15. Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder. Quintero A; Alvarez-Kindelan J; Luque RJ; Gonzalez-Campora R; Requena MJ; Montironi R; Lopez-Beltran A J Clin Pathol; 2006 Jan; 59(1):83-8. PubMed ID: 16394286 [TBL] [Abstract][Full Text] [Related]
16. Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma. Messer J; Shariat SF; Brien JC; Herman MP; Ng CK; Scherr DS; Scoll B; Uzzo RG; Wille M; Eggener SE; Steinberg G; Terrell JD; Lucas SM; Lotan Y; Boorjian SA; Raman JD BJU Int; 2011 Sep; 108(5):701-5. PubMed ID: 21320275 [TBL] [Abstract][Full Text] [Related]
17. Expression of cell-cycle regulatory proteins and their prognostic value in superficial low-grade urothelial cell carcinoma of the bladder. Santos LL; Amaro T; Pereira SA; Lameiras CR; Lopes P; Bento MJ; Oliveira J; Criado B; Lopes CS Eur J Surg Oncol; 2003 Feb; 29(1):74-80. PubMed ID: 12559081 [TBL] [Abstract][Full Text] [Related]
18. Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression. Quentin T; Henke C; Korabiowska M; Schlott T; Zimmerman B; Kunze E Anticancer Res; 2004; 24(2B):1011-23. PubMed ID: 15161057 [TBL] [Abstract][Full Text] [Related]